ONSAGE Trademark

Trademark Overview

On Monday, May 22, 2017, a trademark application was filed for ONSAGE with the United States Patent and Trademark Office. The USPTO has given the ONSAGE trademark a serial number of 87459167. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 9, 2020. This trademark is owned by Pfizer Inc.. The ONSAGE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
onsage

General Information

Serial Number87459167
Word MarkONSAGE
Filing DateMonday, May 22, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 9, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 8, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 26, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, November 9, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 9, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 17, 2020EXTENSION 5 GRANTED
Friday, March 6, 2020EXTENSION 5 FILED
Tuesday, March 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 6, 2020TEAS EXTENSION RECEIVED
Thursday, February 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 17, 2019EXTENSION 4 GRANTED
Tuesday, September 17, 2019EXTENSION 4 FILED
Tuesday, September 17, 2019TEAS EXTENSION RECEIVED
Monday, September 16, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 9, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 8, 2019EXTENSION 3 GRANTED
Friday, March 8, 2019EXTENSION 3 FILED
Friday, March 8, 2019TEAS EXTENSION RECEIVED
Saturday, September 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 13, 2018EXTENSION 2 GRANTED
Thursday, September 13, 2018EXTENSION 2 FILED
Thursday, September 13, 2018TEAS EXTENSION RECEIVED
Thursday, March 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 20, 2018EXTENSION 1 GRANTED
Tuesday, March 20, 2018EXTENSION 1 FILED
Tuesday, March 20, 2018TEAS EXTENSION RECEIVED
Tuesday, October 3, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 8, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 8, 2017PUBLISHED FOR OPPOSITION
Wednesday, July 19, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 27, 2017ASSIGNED TO EXAMINER
Friday, May 26, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 25, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

onsage preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases